TOR - Target of Rapamycin (Hardcover, 2004 ed.)

 TOR, the Target of Rapamycin was discovered a little over ten years ago in a genetic screen in S. cerevisiae in search of mutants resistant to the cytostatic effects of the antimycotic, rapamycin. Recent studies have placed TOR at the interface between nutrient sensing and the regulation of major anbolic and catabolic responses. The editors have gathered the leading figures in the field of TOR and its role in cellular homeostasis and human diseases.

General

Imprint:	Springer-Verlag
Country of origin:	Germany
Series:	Current Topics in Microbiology and Immunology, 279
Release date:	October 2003
First published:	2004
Editors:	George Thomas • David M. Sabatini • Michael N. Hall
Dimensions:	235 x 155 x 18mm (L x W x T)
Format:	Hardcover
Pages:	364
Edition:	2004 ed.
ISBN-13:	978-3-540-00534-6
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Immunology > General
LSN:	3-540-00534-X
Barcode:	9783540005346

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!